© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 13, 964-966,
July 3, 2002
© 2002 Oxford University Press
NEWS |
Vagaries of Research Publishing Again Under the Microscope
| The first 150 words of the full text of this article appear below. |
At a simplistic level, medical journals are an ongoing dialogue among experts about unfolding research that has been scrutinized by experts in the field. But the issues surrounding publishing good science are complex.
Recent debate about how scientific evidence is summarized, how it is interpreted, and how it is presented to the public was fueled last month by the Journal of the American Medical Association, which devoted an entire issue to studies evaluating publication and dissemination of results.
This longstanding and often thorny debate has been fueled by criticisms leveled by some researchers who have studied the quality and dissemination of published research results, by journals grappling with financial disclosure standards, and even by prickly journal editors taking their fellow editors to task.
Study Designs
Analyses of the medical publishing world often focus on consistency and quality in reporting clinical trials and on identifying weaknesses that are believed to be shortcomings
Cookie-Cutter Approach
Financial Conflicts
Evils of Enthusiasm